OHLCX Market Research
Delayed

OGN

Organon & Co. is a global healthcare company that focuses on women’s health, biosimilars, and other established medicines.

−0.02 (−0.14%) Nov 20, 2026 16:01 ET Delayed
Open
13.61
High
13.91
Low
13.61
Prev close
13.91
Volume
3M
Avg vol 10
3M

Today · Market closed · opens Mon 9:30 AM

Price

OGN chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 13.89

Strong sellNeutralStrong buy
Buy
score +0.33 · 18 signalling
8Buy
8Neutral
2Sell

Leaning buy. 8 of 18 signals point up against 2 down, carried by momentum and trend. Volatility is mostly neutral. Volume is mostly neutral. MFI sits in overbought territory. Trend strength is very strong (ADX 41).

How to read this →

Trend

MACD 12, 26, 9
Above signal line and zero
MACD 0.04 · Signal 0.04 · Hist 0.00
Buy
ADX 14
Very strong trend, +DI ahead
ADX 40.56 · +DI 19.12 · −DI 7.48
Buy
Parabolic SAR 0.02, 0.2
Below price, 0.02 under the close
13.87
Buy
Ichimoku 9, 26, 52
Price above cloud, conversion above base
Conv 13.88 · Base 13.83 · A 13.75 · B 13.68
Buy

Momentum

RSI 14
Above midpoint, not overbought
60.52
Neutral
Stoch 14, 3
Elevated, %K still below %D
%K 68.75 · %D 83.33
Neutral
Stoch RSI 14, 14, 3, 3
Elevated, %K just crossed under %D
%K 76.30 · %D 85.42
Neutral
Williams %R 14
Mid-range, falling
−31.25
Neutral
CCI 14
Positive, below +100
56.22
Neutral
MFI 14
Overbought, above 80
84.32
Sell
ROC 12
Price up 0.43% over 12 bars
+0.43%
Buy
AO 5, 35
Above zero, falling
0.09
Neutral
TRIX 18
Just above zero
0.034
Buy
KST 10/15/20/30, 3
Above its signal line
KST 9.70 · Signal 9.63
Buy

Volatility

Bollinger 20, 2
Upper half, %b 0.68
Up 13.96 · Mid 13.85 · Low 13.74
Neutral
Keltner 20, 10, 1.5
Inside the channel, upper half
Up 13.91 · Mid 13.86 · Low 13.80
Neutral

Volume

VWAP 345-bar
Close 36.2% above VWAP
10.20
Buy
Force Index 1
Negative, sellers in control
−71.5K
Sell
ATR
0.04
0.28% of close
A/D Line
−93.2M
cumulative
OBV
264.8M
cumulative
Volume Profile
13.35 – 13.94
POC · bull 298.1M · bear 158.8M · 65 / 35
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

1.02%

Change in value over the past month.

3 month return

1.02%

Change in value over the last three months.

Max drawdown

41.60%

Largest fall from a peak to the low that followed.

Standard deviation

59.93%

How far daily returns stray from their average, annualised.

Sharpe ratio

1.49

Return above the risk-free rate per unit of volatility.

Calmar ratio

2.15

Annualised return against the maximum drawdown.

About

OGN summary

Loading summary…

Questions

OGN, answered

What challenges does Organon face in the market?

Challenges include competition in the pharmaceutical industry and the need to continuously innovate and adapt.

What is Organon’s strategy for growth?

Organon aims to grow through expanding its portfolio in women’s health and entering new markets.

How can investors stay updated on Organon’s performance?

Investors can check the investor relations section of Organon’s website for financial reports and updates.

What are the main therapeutic areas of Organon?

Organon focuses on women’s health, fertility, contraception, and various chronic conditions.

What recent developments have occurred at Organon?

Recent developments include product launches and partnerships aimed at expanding their healthcare offerings.

Is Organon publicly traded?

Yes, Organon is publicly traded on the New York Stock Exchange under the ticker symbol OGN.

What is Organon’s mission?

Organon’s mission is to deliver impactful medicines to improve the lives of women and their families.

How does Organon approach innovation?

Organon emphasizes research and development to innovate within women’s health and other established medicines.

Who are Organon’s major customers?

Organon’s major customers include healthcare providers, hospitals, and pharmacies worldwide.

Where is Organon headquartered?

Organon is headquartered in Jersey City, New Jersey.

Maximize Your OGN Trading Now

Experience the future of trading with ohlcx.com. Our advanced system delivers in-depth analysis and insights for OGN, utilizing state-of-the-art technical tools and strategies. Enhance your market performance today and see how we can elevate your trading results!

Maximize Results Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.